These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 20658967)
1. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Halestrap AP Biochem Soc Trans; 2010 Aug; 38(4):841-60. PubMed ID: 20658967 [TBL] [Abstract][Full Text] [Related]
2. The role of the mitochondrial permeability transition pore in heart disease. Halestrap AP; Pasdois P Biochim Biophys Acta; 2009 Nov; 1787(11):1402-15. PubMed ID: 19168026 [TBL] [Abstract][Full Text] [Related]
4. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. Halestrap AP; Richardson AP J Mol Cell Cardiol; 2015 Jan; 78():129-41. PubMed ID: 25179911 [TBL] [Abstract][Full Text] [Related]
5. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury. Miura T; Tanno M Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. Javadov S; Karmazyn M; Escobales N J Pharmacol Exp Ther; 2009 Sep; 330(3):670-8. PubMed ID: 19509316 [TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition. Sun Y; Zhang Y; Yan M; Wu Y; Zheng X Biol Pharm Bull; 2009 Sep; 32(9):1545-51. PubMed ID: 19721230 [TBL] [Abstract][Full Text] [Related]
8. The role of mitochondria in protection of the heart by preconditioning. Halestrap AP; Clarke SJ; Khaliulin I Biochim Biophys Acta; 2007 Aug; 1767(8):1007-31. PubMed ID: 17631856 [TBL] [Abstract][Full Text] [Related]
9. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864 [TBL] [Abstract][Full Text] [Related]
10. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207 [TBL] [Abstract][Full Text] [Related]
11. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Lim SY; Davidson SM; Hausenloy DJ; Yellon DM Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507 [TBL] [Abstract][Full Text] [Related]
12. Role of the MPTP in conditioning the heart - translatability and mechanism. Ong SB; Dongworth RK; Cabrera-Fuentes HA; Hausenloy DJ Br J Pharmacol; 2015 Apr; 172(8):2074-84. PubMed ID: 25393318 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening. Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678 [TBL] [Abstract][Full Text] [Related]
14. Impact of levosimendan and ischaemia-reperfusion injury on myocardial subsarcolemmal mitochondrial respiratory chain, mitochondrial membrane potential, Ca2+ cycling and ATP synthesis. Sommer S; Leistner M; Aleksic I; Schimmer C; Alhussini K; Kanofsky P; Leyh RG; Sommer SP Eur J Cardiothorac Surg; 2016 Feb; 49(2):e54-62; discussion e62. PubMed ID: 26586791 [TBL] [Abstract][Full Text] [Related]
15. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? Javadov S; Jang S; Parodi-Rullán R; Khuchua Z; Kuznetsov AV Cell Mol Life Sci; 2017 Aug; 74(15):2795-2813. PubMed ID: 28378042 [TBL] [Abstract][Full Text] [Related]
17. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening. Xu T; Ding W; Ao X; Chu X; Wan Q; Wang Y; Xiao D; Yu W; Li M; Yu F; Wang J Redox Biol; 2019 Jan; 20():414-426. PubMed ID: 30415165 [TBL] [Abstract][Full Text] [Related]
18. Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis. Javadov S; Hunter JC; Barreto-Torres G; Parodi-Rullan R Cell Physiol Biochem; 2011; 27(3-4):179-90. PubMed ID: 21471706 [TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017 [TBL] [Abstract][Full Text] [Related]
20. Pre-treatment of a single high-dose of atorvastatin provided cardioprotection in different ischaemia/reperfusion models via activating mitochondrial KATP channel. Zhao Z; Cui W; Zhang H; Gao H; Li X; Wang Y; Hu H; Li B Eur J Pharmacol; 2015 Mar; 751():89-98. PubMed ID: 25641746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]